Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Mar 27, 2001; 98(7): 3832–3836.
Published online Mar 13, 2001. doi:  10.1073/pnas.051515498
PMCID: PMC31138
Cell Biology

Profilin I is essential for cell survival and cell division in early mouse development

Abstract

Profilins are thought to play a central role in the regulation of de novo actin assembly by preventing spontaneous actin polymerization through the binding of actin monomers, and the adding of monomeric actin to the barbed actin-filament ends. Other cellular functions of profilin in membrane trafficking and lipid based signaling are also likely. Binding of profilins to signaling molecules such as Arp2/3 complex, Mena, VASP, N-WASP, dynamin I, and others, further implicates profilin and actin as regulators of diverse motile activities. In mouse, two profilins are expressed from two distinct genes. Profilin I is expressed at high levels in all tissues and throughout development, whereas profilin II is expressed in neuronal cells. To examine the function of profilin I in vivo, we generated a null profilin I (pfn1ko) allele in mice. Homozygous pfn1ko/ko mice are not viable. Pfn1ko/ko embryos died as early as the two-cell stage, and no pfn1ko/ko blastocysts were detectable. Adult pfn1ko/wt mice show a 50% reduction in profilin I expression with no apparent impairment of cell function. However, pfn1ko/wt embryos have reduced survival during embryogenesis compared with wild type. Although weakly expressed in early embryos, profilin II cannot compensate for lack of profilin I. Our results indicate that mouse profilin I is an essential protein that has dosage-dependent effects on cell division and survival during embryogenesis.

Profilins are ubiquitous proteins found in mammals (1), animal cells (2), plants (3), and viruses (4). Profilins sequester actin monomers in a 1:1 complex and inhibit actin polymerization (1). When bound to actin, profilin functions as an ATP nucleotide exchange factor recharging ADP-actin with ATP (5). Phosphoinositides were shown to dissociate the profilin–actin complex, suggesting that release of free ATP-actin at the plasma membrane could promote polymerization locally (6). Because of its affinity for phosphatidylinositol 4,5-bisphosphate, profilin also functions as a regulator of the signal transduction pathway through phospholipase C-γ1 (7).

Recent biochemical studies have suggested that profilin plays a key role in promoting actin assembly at the plasma membrane that drives cell motility and other actin-linked processes (810). Profilin also has been implicated in the motility of the intracellular pathogen Listeria monocytogenes (11), although an essential role for Listeria motility has been brought into question by recent results (12).

Despite a wealth of biochemical data on profilin function, the in vivo role is still under debate. Part of the complication is that profilin interacts not only with actin but also with a large number of ligands such as Mena (13), VASP (14), dynamin I (15), gephyrin (16), and SMN (17), and that this ligand binding might be an important aspect of profilin function. The promiscuity of profilin for a plethora of signaling molecules provides links between a variety of cellular processes and actin remodeling, but it also complicates the interpretation of profilin's function in vivo.

Whereas profilin I has been suggested as a tumor suppressor (18), no human diseases linked to profilin have been described, and no mouse models are available yet. In mouse, two profilin genes (profilin I and profilin II) that are 62% identical have been described. Biochemically, both isoforms are related closely in respect to actin binding, phosphatidylinositol bisphosphate binding, and their affinity for poly(l-proline) (19, 20). The major differences between the two profilin isoforms are their distinct expression patterns and their isoform-specific interactions with certain ligands, suggesting unique functions of the isoforms in vivo (15). Recently, we identified a splice form of profilin II (profilin IIB) in mouse that is generated in very low amounts in certain tissues (21).

Loss-of-function analysis in different model systems has provided further information on the role of profilin. In Schizosaccharomyces pombe (22) and Drosophila melanogaster (23), deletion of the one profilin gene resulted in lethal phenotypes, whereas in Saccharomyces cerevisiae severe growth reduction was observed (24). The amoeba Dictyostelium discoideum carries two profilin genes and only ablation of both isoforms reveals defects in cytokinesis. Nevertheless, double mutants can grow under certain conditions without any detectable profilin (25). In Dictyostelium cells lacking profilin, F-actin contents are increased. This increase formally contradicts the predictions for a protein required to promote actin polymerization, but is in agreement with profilin as a regulator of the monomeric actin pool. These analyses show that evaluation of profilins' in vivo function very much depends on the studied cell type and the organism.

Here we compare the expression pattern of mouse profilin I and profilin II, and report the generation of a conventional gene knockout for the profilin I gene. Our results show an essential role for profilin I in early mouse development during the first cleavages. Profilin II is not able to compensate and most likely has a more specific function in neuronal cells.

Materials and Methods

Generation of Profilin I Knockout Mice.

Embryonic stem (ES) cell culture of J1 cells (26) and blastocyst injections were performed as described (27). Three independent, targeted ES clones were used to produce transgenic mice. Two clones were injected into BALB/c blastocysts and maintained in the BALB/c background, and the third clone was injected into C57 blastocysts. In all three lines, the profilin I mutation proved to be an early embryonic lethal mutation.

Genotyping of Blastocysts.

Blastocysts were collected and individually lysed by adding Chelex-100 beads and boiling for 5 min. The supernatant was used directly for PCR. Two primer pairs were used in combination to amplify a 140-bp fragment from the wild-type profilin I allele (pfn1-A, 5′-CCA TGG CCG GGT GGA ACG CC-3′; pfn1-B, 5′-GTA CCG TAA TGC TAA CGA AGG-3′) and a 400-bp fragment from the neomycin-resistance gene in the disrupted allele (neo-A, 5′-ATT GAA CAA GAT GGA TTG CAC-3′; neo-B, 5′-CGT CCA GAT CAT CCT GAT C-3′). Because of the 1.8-kb insertion, only the internal neofragment would be amplified in homozygous mutants. In wild-type embryos, only the 140-bp product was detected. PCR products were separated, transferred onto membrane, and probed with the neomycin-resistance gene and profilin-specific probes.

Quantitation of Profilins I and II in Tissues and Embryos.

Defined amounts of total lysates were subjected to SDS/PAGE and were transferred to membranes, and the filters were probed with the respective antibodies. Profilin antibodies were raised in rabbits against recombinant human profilins I and II. Both antibodies were isoform specific and crossreacted with mouse profilin I and the major mouse profilin II isoform, profilin IIA. Expression of the profilin IIB isoform is very low (21) and can be neglected for the absolute quantitation of profilin II in tissues. Serial dilutions of recombinant native profilins I and IIA were run as standards in parallel on the same gel. Signals were detected with enhanced chemiluminescence (ECL) reagent (Amersham Pharmacia) and the intensities were determined by using IMAGE 1.49.

Results

We chose to study the in vivo functions of mammalian profilins by using the mouse as a model system. To begin, we examined the relative expression of profilins I and II in different tissues and at different developmental stages by using isoform-specific antibodies (Fig. (Fig.1).1). Profilin I was expressed in all tissues, and was particularly high in the spleen, thymus, lung, and gut, but relatively low in the heart (Fig. (Fig.11a). In contrast, profilin II was expressed at high levels only in the brain (Fig. (Fig.11a). During embryonic development, profilin I was expressed highly at all stages, including ES cells, whereas profilin II was expressed at low levels in ES cells and early embryos, with peak expression around E13 (Fig. (Fig.11b). This increase in profilin IIA expression correlates with rapid development of the brain, supporting the notion that profilin II has acquired a specific function in neural cells and development.

Figure 1
Expression of profilin I and profilin IIA protein in mouse tissues and during development. (a) Equal amounts of tissue extracts from adult mice were separated by SDS/PAGE, transferred, and probed with affinity-purified polyclonal antibodies ...

Quantitative analysis indicated that profilin I occurred at highest levels in mouse platelets (0.4% of total cell protein, Fig. Fig.11c) with comparable levels in other tissues, apart from brain. Profilin I expression in skeletal muscle is very low (data not shown). In contrast, profilin II expression was complementary to that of profilin I, being very high in brain (0.15% of total cell protein) and very low elsewhere. In summary, all tested mouse tissues—except skeletal muscle—contained 0.2–0.4% profilin I (30–60 μM), which is about half the concentration of actin in cells. This high-level expression suggests it has a general function in all tissues and throughout development. Profilin I expression is particularly high in tissues undergoing active proliferation, consistent with a role in cell growth or division.

To test the in vivo role of mouse profilin I, we generated a pfn1ko allele by gene targeting in ES cells. In the gene-targeting construct, the neomycin-resistance cassette was inserted at the ATG start codon of the pfn1 locus, avoiding the production of any possible truncated protein (Fig. (Fig.22a). ES clones bearing a targeted pfn1ko allele were identified at a frequency of 1/18 neomycin-resistant clones by Southern blot analysis (Fig. (Fig.22b). Three independent ES clones were injected into blastocysts, and all resulting chimeras passed on the mutation to offspring. Subsequent crosses of heterozygous pfn1ko/wt mice did not yield any homozygous pfn1ko/ko offspring, indicating that the mutation leads to an embryonic lethal phenotype (Table (Table1).1). This result was seen in mice derived from all three independently targeted ES clones, excluding a nonspecific effect from secondary mutation (data not shown).

Figure 2
Generation of profilin I knockout mice. (a) Map of the mouse profilin I gene (Top), the targeting vector (Middle) consisting of an 8.5-kb BglII (Bg) fragment, and the targeted locus (Bottom) are shown. Filled rectangles indicate coding exons 1, 2, ...
Table 1
Genotype of adult mice and embryos from profilin I mutant crossing

pfn1ko/wt intercross embryo analysis showed that no pfn1ko/ko embryos were present at midgestation (E9.5–11.5), or even at E3.5, the preimplantation blastocyst stage (Table (Table1).1). These results show that profilin I is indispensable for the earliest steps in mouse development. To explore this phenomenon in greater detail, we cultured embryos at the 2-cell stage from wild type and pfn1ko/wt intercross matings, allowing them to differentiate toward blastocysts. Almost all (92.5%; n = 81) of the wild-type embryos developed into morula/blastocysts (Fig. (Fig.33a). In contrast, only 52.5% (n = 97) of pfn1ko/wt intercross-derived embryos developed properly (Fig. (Fig.33b), consistent with the premature death of about 1/4 of the pfn1ko/ko embryos, and perhaps some of the heterozygotes (see below). These failing embryos displayed a consistent pattern of condensation and fragmentation, with some variation in the time of death ranging from the two-cell to the four-cell stage.

Figure 3
In vitro development of two-cell embryos from wild-type (pfn1wt/wt) and heterozygous (pfn1ko/wt) crossings. Embryos were flushed at E1.5 and cultured for 2 days according to standard procedures (34) to allow development into morulas/blastocysts. ...

Immunostaining of wild-type compacted morulas with purified profilin I antibodies revealed a diffuse cytoplasmic localization in the blastomeres with some enrichment in the cell cortex (Fig. (Fig.33c), consistent with its proposed role in early cleavages. Experiments to stain earlier embryos to determine their genotype were problematic because of the maternal contribution of profilin I and the rapid necrosis in homozygous mutants. Similarly, the severe deterioration and small size of these embryos made it impossible to analyze morphological alterations in the cytoskeleton in any detail.

These results suggested clearly that the profilin I null state was a cell-lethal event, which occurred rapidly after zygote formation, presumably as cellular pools of maternally derived profilin mRNA and protein declined. Additional evidence for the early embryonic lethality because of lack of profilin I also was seen in that we were unable to isolate pfn1ko/ko ES cell lines by high-dose G-418 selection, in contrast to several other genes for which null alleles have been generated by this method (27, 28).

pfn1ko/wt mice were viable, had normal longevity, and normal phenotype under standard mouse colony conditions. Histological analysis of tissues from pfn1ko/wt mice showed no abnormalities (data not shown). Western blot analysis confirmed that in pfn1ko/wt mice, profilin I expression was reduced by about 50% (Fig. (Fig.4),4), and was independent of the parent of origin of the pfn1ko allele (data not shown). Several pfn1ko/wt cell types were studied and all appeared normal. For example, pfn1ko/wt platelets had resting and stimulated F-actin levels similar to those of wild type, and pfn1ko/wt embryonic fibroblasts had normal growth characteristics and cytoskeletal architecture (data not shown).

Figure 4
Levels of profilin I in platelets and thymocytes from heterozygous mutant mice. (a) Equal amounts of platelet lysate from pfn1wt/wt and pfn1ko/wt mice were separated by SDS/PAGE, transferred, and probed with a profilin I-specific antibody ...

Although pfn1ko/wt mice were viable, there was a selective loss of such embryos during embryonic development (Table (Table1).1). The ratio of wild-type to pfn1ko/wt mice in the viable offspring from pfn1ko/wt intercrosses was 1:1.3 instead of the expected 1:2 (P < 0.001 by χ2 test), and this effect was seen in mixed BALB/c-129/SvJae and mixed C57BL/6–129/SvJae backgrounds. To examine whether the survival of pfn1ko/wt embryos was affected by parental genotype, we crossed wild-type males with pfn1ko/wt females and vice versa. The loss of pfn1ko/wt embryos appeared to occur exclusively when the mother was pfn1ko/wt and therefore contributed the pfn1ko allele to the embryo (Table (Table1), 1), suggesting a maternal effect because of the decreased level of supplied profilin I in the oocytes. Interestingly, the haploid pfn1ko sperms are apparently viable and fully functional as indicated by the numbers (Table (Table11).

The reduction in pfn1ko/wt viability was even more dramatic in an N10 (10 backcrosses) C57BL/6 congenic strain derived from C57BL/6 and 129/SvJae (Table (Table1).1). In these mice, the proportion of pfn1ko/wt offspring fell to 35% from the expected 67% in pfn1ko/wt intercrosses, and the fetal loss was again much more severe when the mother carried the pfn1ko allele. Timed embryo analysis in these congenic pfn1ko/wt intercrosses indicated that at all stages from E8 to E18, the proportion of pfn1ko/wt embryos was reduced from the expected 67% but not as low as that seen in newborns. These observations suggested there were two stages at which pfn1ko/wt embryos failed—an early time point before E8 and a second time point in the perinatal interval. The early phase of pfn1ko/wt embryo loss could be caused by reduced levels of profilin in the early embryo, because the eggs from pfn1ko/wt mothers began with a one-half complement of profilin mRNA and protein. The perinatal mortality could be caused by defects in the mother or the fetus or a combination of the two.

Discussion

In summary, the profilin I gene exerts a dosage-dependent effect on viability in the mouse. Profilin I null zygotes die shortly after fertilization, whereas pfn1ko/wt mice have reduced survival, which is accentuated by maternal passage of the pfn1ko allele. The reduced survival of pfn1ko/wt mice in mixed genetic backgrounds, which is further decreased on formation of a congenic, suggests that there are several loci that interact with the profilin I locus to influence the viability of these mice. One candidate gene, alleles of which might modify the viability of pfn1ko/wt mice, is Mena. Mena-null mice display axonal pathfinding defects resulting in subtle brain structural abnormalities but are viable with normal fertility, whereas the addition of one pfn1ko allele to the Mena-null background leads to embryonic death in late gestation (29). Mena is a profilin I ligand and functions through the profilin pathway to regulate actin dynamics (13).

Although profilin II is expressed weakly in ES cells and early embryos, it is not sufficient to rescue the deficiency in profilin I, suggesting a unique function in brain. This possibility is also supported by preliminary results on profilin II-deficient mice (A. Di Nardo and W.W., unpublished data). Analysis of combined profilin I and II alleles may resolve whether any functional redundancy exists between the two proteins, and conditional loss-of-function alleles for profilin I will facilitate our further analysis of roles in development and in nondividing somatic cells.

Profilin is known to participate in the actin dynamics that characterize many forms of cellular motility, has multiple binding partners, and also may affect phospholipid metabolism and signaling. It is currently uncertain which of these properties contributes to the marked effects of profilin loss in mouse. Biochemical studies in Acanthamoeba suggest that actin binding is the primary function of profilin (30). However, the binding of other ligands via the poly(l-proline) binding site in profilin is also necessary as revealed by rescue experiments in yeast (31) and Dictyostelium (32). Much as profilin can sequester actin monomers, the interaction with ligands such as Arp2/3 complex (33), VASP (14), Mena (13), drebrin, gephyrin (16), SMN (17), and others may serve to sequester these ligands until they are needed to trigger a specific cellular process. Because the viability of profilin I null embryos is so limited, we speculate that leaving all of the profilin I ligands unlocked could be one cause for the cell lethal phenotype. The conditional replacement of wild-type profilin I by mutant alleles in mouse may define the relationship between the actin and poly(l-proline) ligand-binding properties of profilin I.

Acknowledgments

We thank members of the Witke and Rajewsky laboratories for helpful comments on the manuscript. We also thank E. Li and R. Jaenisch for the J1 ES cell line (Massachusetts Institute of Technology, Cambridge, MA). J.D.S. was supported by a postdoctoral fellowship from the European Molecular Biology Organization and the Human Frontiers Science Program.

Abbreviations

ES
embryonic stem
En
embryonic day n

Footnotes

This paper was submitted directly (Track II) to the PNAS office.

References

1. Carlsson L, Nystrom L E, Sundkvist I, Markey F, Lindberg U. J Mol Biol. 1977;115:465–483. [PubMed]
2. Reichstein E, Korn E D. J Biol Chem. 1979;254:6174–6179. [PubMed]
3. Valenta R, Duchene M, Ebner C, Valent P, Sillaber C, Deviller P, Ferreira F, Tejkl M, Edelmann H, Kraft D, et al. J Exp Med. 1992;175:377–385. [PMC free article] [PubMed]
4. Machesky L M, Cole N B, Moss B, Pollard T D. Biochemistry. 1994;33:10815–10824. [PubMed]
5. Goldschmidt-Clermont P J, Furman M I, Wachsstock D, Safer D, Nachmias V T, Pollard T D. Mol Biol Cell. 1992;3:1015–1024. [PMC free article] [PubMed]
6. Lassing I, Lindberg U. Nature (London) 1985;314:472–474. [PubMed]
7. Goldschmidt-Clermont P J, Kim J W, Machesky L M, Rhee S G, Pollard T D. Science. 1991;251:1231–1233. [PubMed]
8. Blanchoin L, Amann K J, Higgs H N, Marchand J B, Kaiser D A, Pollard T D. Nature (London) 2000;404:1007–1011. [PubMed]
9. Yang C, Huang M, DeBiasio J, Pring M, Joyce M, Miki H, Takenawa T, Zigmond S H. J Cell Biol. 2000;150:1001–1102. [PMC free article] [PubMed]
10. Kang F, Purich D L, Southwick F S. J Biol Chem. 1999;274:36963–36972. [PubMed]
11. Theriot J A, Rosenblatt J, Portnoy D A, Goldschmidt-Clermont P J, Mitchison T J. Cell. 1994;76:505–517. [PubMed]
12. Loisel T P, Boujemaa R, Pantaloni D, Carlier M F. Nature (London) 1999;401:613–616. [PubMed]
13. Gertler F B, Niebuhr K, Reinhard M, Wehland J, Soriano P. Cell. 1996;87:227–239. [PubMed]
14. Reinhard M, Giehl K, Abel K, Haffner C, Jarchau T, Hoppe V, Jockusch B M, Walter U. EMBO J. 1995;14:1583–1589. [PMC free article] [PubMed]
15. Witke W, Podtelejnikov A V, Di Nardo A, Sutherland J D, Gurniak C B, Dotti C, Mann M. EMBO J. 1998;17:967–976. [PMC free article] [PubMed]
16. Mammoto A, Sasaki T, Asakura T, Hotta I, Imamura H, Takahashi K, Matsuura Y, Shirao T, Takai Y. Biochem Biophys Res Commun. 1998;243:86–89. [PubMed]
17. Giesemann T, Rathke-Hartlieb S, Rothkegel M, Bartsch J W, Buchmeier S, Jockusch B M, Jockusch H. J Biol Chem. 1999;274:37908–37914. [PubMed]
18. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estevez-Schwarz L, Schlag P M, et al. J Exp Med. 2000;191:1675–1686. [PMC free article] [PubMed]
19. Gieselmann R, Kwiatkowski D J, Janmey P A, Witke W. Eur J Biochem. 1995;229:621–628. [PubMed]
20. Lambrechts A, van Damme J, Goethals M, Vandekerckhove J, Ampe C. Eur J Biochem. 1995;230:281–286. [PubMed]
21. Di Nardo A, Gareus R, Kwiatkowski D, Witke W. J Cell Sci. 2000;113:3795–3803. [PubMed]
22. Balasubramanian M K, Hirani B R, Burke J D, Gould K L. J Cell Biol. 1994;125:1289–1301. [PMC free article] [PubMed]
23. Verheyen E M, Cooley L. Development (Cambridge, UK) 1994;120:717–728. [PubMed]
24. Haarer B K, Lillie S H, Adams A E, Magdolen V, Bandlow W, Brown S S. J Cell Biol. 1990;110:105–114. [PMC free article] [PubMed]
25. Haugwitz M, Noegel A A, Karakesisoglou J, Schleicher M. Cell. 1994;79:303–314. [PubMed]
26. Li E, Bestor T H, Jaenisch R. Cell. 1992;69:915–926. [PubMed]
27. Witke W, Sharpe A H, Hartwig J H, Azuma T, Stossel T P, Kwiatkowski D J. Cell. 1995;81:41–51. [PubMed]
28. Mortensen R M, Conner D A, Chao S, Geisterfer-Lowrance A A, Seidman J G. Mol Cell Biol. 1992;12:2391–2395. [PMC free article] [PubMed]
29. Lanier L M, Gates M A, Witke W, Menzies A S, Wehman A M, Macklis J D, Kwiatkowski D, Soriano P, Gertler F B. Neuron. 1999;22:313–325. [PubMed]
30. Kaiser D A, Vinson V K, Murphy D B, Pollard T D. J Cell Sci. 1999;112:3779–3790. [PubMed]
31. Ostrander D B, Ernst E G, Lavoie T B, Gorman J A. Eur J Biochem. 1999;262:26–35. [PubMed]
32. Lee S S, Karakesisoglou I, Noegel A A, Rieger D, Schleicher M. Eur J Cell Biol. 2000;79:92–103. [PubMed]
33. Machesky L M, Atkinson S J, Ampe C, Vandekerckhove J, Pollard T D. J Cell Biol. 1994;127:107–115. [PMC free article] [PubMed]
34. Hogan B, Constantini R B F, Lacy E. Manipulating the Mouse Embryo. Plainview, NY: Cold Spring Harbor Lab. Press; 1994.

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Gene
    Gene
    Gene links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene
    HomoloGene links
  • OMIM
    OMIM
    OMIM record citing PubMed
  • Pathways + GO
    Pathways + GO
    Pathways, annotations and biological systems (BioSystems) that cite the current article.
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links
  • Taxonomy
    Taxonomy
    Related taxonomy entry
  • Taxonomy Tree
    Taxonomy Tree

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...